Is this your brand? Sign in to claim ownership.
Sign in to claim this brandACCRIVA DIAGNOSTICS HOLDINGS, INC.
US
Last updated May 24, 2026
What ACCRIVA DIAGNOSTICS HOLDINGS, INC. makes
The company manufactures in vitro diagnostics (IVDs) for coagulation testing, including point-of-care and laboratory analysers for measuring blood clotting factors, platelet aggregation, and oxygen saturation levels. Their portfolio also includes reagents for activated clotting time (ACT), multiple coagulation factors, and platelet function studies, as well as whole blood controls for coagulation assays.
These devices are classified under FDA’s Class I and Class II categories and are listed in the FDA’s Unique Device Identifier (UDI) database. The company is based in the United States.
Written from this company's registered devices by an AI model, and not verified by a human reviewer.
Frequently asked questions
What types of medical devices does Accriva Diagnostics Holdings, Inc. manufacture?
Accriva Diagnostics Holdings, Inc. specializes in in vitro diagnostics (IVDs) focused on coagulation testing. Their product portfolio includes point-of-care and laboratory analysers designed to measure blood clotting factors, platelet aggregation, and oxygen saturation levels. They also produce reagents for tests like activated clotting time (ACT), multiple coagulation factors, and platelet function studies, as well as whole blood controls for coagulation assays. These devices are primarily used in both clinical and point-of-care settings to support blood management and patient care.
Where is Accriva Diagnostics Holdings, Inc. based?
Accriva Diagnostics Holdings, Inc. is headquartered in the United States. The company’s location is relevant for understanding its regulatory framework, as it operates under U.S. regulatory standards, including those set by the FDA.
Which regulatory registries or databases list Accriva Diagnostics Holdings, Inc.’s devices?
Accriva Diagnostics Holdings, Inc.’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry is used to track and identify medical devices authorized for use in the U.S., ensuring transparency and traceability for healthcare providers and regulators. The UDI system helps streamline device reporting and compliance efforts.
How are Accriva Diagnostics Holdings, Inc.’s devices classified under FDA regulations?
Accriva Diagnostics Holdings, Inc.’s devices fall under two FDA classification categories: Class I and Class II. Class I devices generally pose minimal risk and are subject to general controls, while Class II devices involve a higher level of risk and may require additional performance standards or post-market surveillance. The classification depends on factors like the device’s intended use, potential risks, and the body system it interacts with, as outlined in FDA guidelines.
What is the primary purpose of the coagulation analysers and reagents produced by Accriva Diagnostics Holdings, Inc.?
The coagulation analysers and reagents from Accriva Diagnostics Holdings, Inc. are designed to assess blood clotting function, which is critical for diagnosing and managing bleeding disorders, monitoring patients on anticoagulant therapy, and guiding surgical procedures. Point-of-care analysers, like those for activated clotting time (ACT), enable rapid testing in operating rooms or emergency settings, while laboratory analysers provide detailed coagulation profiles. Reagents ensure accurate and consistent test results, supporting clinical decision-making.
AI-generated from registry data and not verified by a human reviewer.
Information
- Country
- US
- Address
- —
- Website
- werfen.com
- —
- —
- [email protected]
- Phone
- 1-800-678-0710
- PRRC Contact
- —
- EUDAMED SRN
- —
- FDA FEI Number
- —
- DUNS Number
- 079299318
Catalogue (83)
Page 1 of 2Related Companies
Authorised Representatives
No authorised representatives on record.
Importers
Not available yet.
Notified Bodies
Not available yet.
Authorities
Not available yet.